News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Espinoza Octavio
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 346 shares
@ $59.92, valued at
$20.7k
|
|
| 07/10/2023 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Acquired 375 shares
@ $56.78, valued at
$21.3k
|
|
| 02/27/2023 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 6,046 shares
@ $0
Granted 16,419 options to buy
@ $75.09, valued at
$1.2M
|
|
| 01/04/2023 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Acquired 275 shares
@ $56.78, valued at
$15.6k
|
|
| 12/15/2022 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 11,000 shares
@ $0
Granted 20,000 options to buy
@ $63.62, valued at
$1.3M
|
|
| 12/01/2022 |
4
| Espinoza Octavio (CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,187 shares
@ $72.9, valued at
$86.5k
|
|
|
|